Suda Ltd. develops pharmaceuticals and distributes medical devices and consumables. Its activities include pharmaceutical development of drug delivery technology and medical devices and consumables distribution. The company operates through following segment: Suda, Westcoast Surgical and Medical Supplies; and Malaria Research Company. The Suda segment includes research and development to create new human pharmaceutical products by combining proven drugs with innovated, patented, delivery technologies. The Westcoast Surgical and Medical Supplies segment includes sales and logistics operation for medical devices and consumables. The Malaria Research Company segment segment is the pharmaceutical development segment for the treatment of malaria. Suda was founded on December 21, 1999 and is headquartered in Osborne Park, Australia.
|Market Price at 20-11-2017||$0.02|
|Price to Earnings Ratio||-16.78|
|Market Capitalisation||$23.18 (million)|
|Return on Equity (ROE)||-7.36%|